Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: a dual center retrospective analysis.

Stephan Mielke,Mathias Lutz,J Schmidhuber,Markus Kapp,Diana Ditz,Julia Ammer,H Einsele,G U Grigoleit,E. Holler,Daniel Wolff

Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: a dual center retrospective analysis.

2014

Stephan Mielke
Mathias Lutz
J Schmidhuber
Markus Kapp
Diana Ditz
Julia Ammer
H Einsele
G U Grigoleit
E. Holler
Daniel Wolff

Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: A dual center retrospective analysis

Keywords:

Progenitor cell
Immunology
Diabetes mellitus
Stem cell
Graft-versus-host disease
Transplantation
Disease
Medicine
Everolimus
Salvage therapy
Refractory
Immunosuppression
retrospective analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations